1 year return (CAGR)
186.63%
Sellas Life Sciences Group Inc Exchange (NASDAQ, USD)
SLS
13.95
-0.22 (-4.27%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
49.68%
5 year return (CAGR)
-8.95%
10 year return (CAGR)
-59.63%
Computer Modeling Group 2027 Q1 - Turnarounds seldom turn?
Read MoreMarketcap
909.75M
Price/Sales
-
Ent value
845.33M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.10 |
| Daily high | 5.11 |
| Daily low | 4.88 |
| Daily Volume | 4.09M |
| All-time high | 335364.00 |
| 1y analyst estimate | 32.50 |
| Beta | 2.49 |
| EPS (TTM) | -0.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 13 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SLS | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.19% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -89.38% | -10.69% |
| Avg time to new high | 2284 days | 12 days |
| Max time to new high | 4567 days | 1805 days |
News
